These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 18198474)
1. Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy). Nakagawa T; Kaneko S J Pharmacol Sci; 2008 Jan; 106(1):2-8. PubMed ID: 18198474 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons. Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325 [TBL] [Abstract][Full Text] [Related]
3. Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. Nakagawa T; Suzuki Y; Nagayasu K; Kitaichi M; Shirakawa H; Kaneko S PLoS One; 2011; 6(9):e24865. PubMed ID: 21980362 [TBL] [Abstract][Full Text] [Related]
4. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Seger D Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Halpin LE; Collins SA; Yamamoto BK Life Sci; 2014 Feb; 97(1):37-44. PubMed ID: 23892199 [TBL] [Abstract][Full Text] [Related]
7. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain. Kirilly E Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361 [TBL] [Abstract][Full Text] [Related]
8. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Achat-Mendes C; Ali SF; Itzhak Y Neuropsychopharmacology; 2005 Jun; 30(6):1128-37. PubMed ID: 15688084 [TBL] [Abstract][Full Text] [Related]
10. [In vitro assessment of neuropsychotoxicity of abused drugs using organotypic slice cultures]. Nakagawa T; Kaneko S Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):166-71. PubMed ID: 18646642 [TBL] [Abstract][Full Text] [Related]
11. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK; Meyer JS J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520 [TBL] [Abstract][Full Text] [Related]
12. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197 [TBL] [Abstract][Full Text] [Related]
14. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats. Noworyta-Sokołowska K; Kamińska K; Kreiner G; Rogóż Z; Gołembiowska K Neurotox Res; 2016 Nov; 30(4):606-619. PubMed ID: 27461536 [TBL] [Abstract][Full Text] [Related]
15. 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. Sogawa C; Sogawa N; Tagawa J; Fujino A; Ohyama K; Asanuma M; Funada M; Kitayama S Toxicol Lett; 2007 Apr; 170(1):75-82. PubMed ID: 17382495 [TBL] [Abstract][Full Text] [Related]
16. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage. Costa G; Morelli M; Simola N Neurotox Res; 2017 Nov; 32(4):563-574. PubMed ID: 28597409 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'. Itzhak Y; Achat-Mendes C IUBMB Life; 2004 May; 56(5):249-55. PubMed ID: 15370888 [TBL] [Abstract][Full Text] [Related]
18. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743 [TBL] [Abstract][Full Text] [Related]
19. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. Williams MT; Herring NR; Schaefer TL; Skelton MR; Campbell NG; Lipton JW; McCrea AE; Vorhees CV Neuropsychopharmacology; 2007 Jun; 32(6):1404-20. PubMed ID: 17047665 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice. Ago Y; Nakamura S; Baba A; Matsuda T J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]